Dixon Hubard Feinour & Brown’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$890K Hold
20,218
0.11% 153
2022
Q1
$806K Buy
20,218
+200
+1% +$7.12K 0.08% 175
2021
Q4
$805K Buy
20,018
+1,050
+6% +$39.2K 0.08% 170
2021
Q3
$772K Buy
18,968
+5,000
+36% +$209K 0.16% 94
2021
Q2
$634K Sell
13,968
-13,968
-50% -$618K 0.13% 106
2021
Q1
$949K Buy
27,936
+13,968
+100% +$638K 0.12% 114
2020
Q4
$367K Hold
13,968
0.09% 119
2020
Q3
$367K Hold
13,968
0.09% 119
2020
Q2
$380K Hold
13,968
0.1% 114
2020
Q1
$251K Hold
13,968
0.08% 134
2019
Q4
$248K Hold
13,968
0.06% 155
2019
Q3
$217K Sell
13,968
-1,794
-11% -$29.6K 0.06% 163
2019
Q2
$271K Sell
15,762
-940
-6% -$15.2K 0.08% 146
2019
Q1
$269K Hold
16,702
0.08% 143
2018
Q4
$244K Hold
16,702
0.09% 134
2018
Q3
$303K Hold
16,702
0.08% 134
2018
Q2
$282K Sell
16,702
-535
-3% -$10.1K 0.08% 135
2018
Q1
$338K Hold
17,237
0.09% 138
2017
Q4
$349K Sell
17,237
-707
-4% -$13K 0.09% 139
2017
Q3
$312K Hold
17,944
0.09% 142
2017
Q2
$230K Hold
17,944
0.07% 160
2017
Q1
$233K Hold
17,944
0.07% 155
2016
Q4
$177K Hold
17,944
0.06% 164
2016
Q3
$217K Buy
+17,944
New +$183K 0.07% 160

Other funds holding HALO

Dixon Hubard Feinour & Brown's HALO Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown held its Halozyme (HALO) position steady in Q2 2022 at 20,218 shares worth $890K. The position accounts for 0.11% of the portfolio, ranked #153.

Dixon Hubard Feinour & Brown first reported a position in HALO in Q3 2016 and has held it in 24 quarters since. The position peaked at $949K in Q1 2021. 367 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

  • Dixon Hubard Feinour & Brown held 20,218 shares of Halozyme worth $890K as of Q2 2022.
  • Dixon Hubard Feinour & Brown left its Halozyme share count unchanged in Q2 2022.
  • Halozyme made up 0.11% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #153 holding.
  • Dixon Hubard Feinour & Brown first reported a position in Halozyme in Q3 2016 and has held it in 24 quarters since.
  • Dixon Hubard Feinour & Brown's Halozyme position peaked at $949K in Q1 2021.
  • 367 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.